No Detail Found!

Premenstrual estradiol levels in female patients with ischemic stroke and post-ischemic stroke epilepsy.

Author(s)
Samir Mohammed Abdulfattah Attia University Medical Centre, Umm Al-Qura University, Makkah, Ministry of Health, Saudi Arabia
Yaser Hasan Bahakeem University Medical Centre, Umm Al-Qura University, Makkah, Ministry of Health, Saudi Arabia
Lubna Naz Department of Physiology, University of Karachi,Karachi,Pakistan
Zahir Hussain Department of Physiology, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia;University Medical Centre, Umm Al-Qura University, Makkah, Ministry of Health, Saudi Arabia
Gisela H. Maia EEG Department, Medibrain-Center for Neurophysiology Studies, Vila do Conde, Porto, Portugal.
Mamdouh H. Kalakatawi Al-Noor Specialist Hospital,Makkah, Ministry of Health,Saudi Arabia
Hani Faidah Al-Noor Specialist Hospital, Makkah, Ministry of Health, Saudi Arabia; Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
Nazish Iqbal Khan Department of Physiology, University of Karachi,Karachi,Pakistan
Ghazala Yasmeen Department of Physiology, University of Karachi,Karachi,Pakistan
Samia Mushtaq Department of Physiology, University of Karachi,Karachi,Pakistan
Amal Alkhotani Department of Medicine, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia
Huma Zahir Biomedical, Computational and Theoretical Research (BCTR) Lab, DHA,Karachi,Pakistan
Mohammed A. Bafail Department of Physiology, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia
Abdulhalim S. Serafi Department of Physiology, Faculty of Medicine, Umm Al-Qura University,Makkah,Saudi Arabia
Abstract
Estrogen serves as preischemic treatment for cerebral ischemia protection and hence it is considered as vasoprotective and neuroprotective agent. The involvement of estrogen in epilepsy, ischemia, and other disorders has recently been comprehensively reviewed. Premenstrual estradiol 17-ß serum levels (pmol/l) (Mean ± SEM) using ELISA kits in normal control (NC, n: 40) women subjects and women patients with ischemic stroke (IS, n: 37) and post-ischemic stroke epilepsy (PISE, n: 36) were found respectively as 221.125 ± 10.3989, 201.9459±8.6548 and 237.9722 ± 12.2337. Statistical analysis showed non-significant results for NC vs. IS and NC vs. PISE whereas IS vs. PISE showed significant variations (p=0.0183). One way ANOVA and Tukey-Kramer test for normal control subjects (NC) and subjects with ischemic stroke (IS) and post-ischemic stroke epilepsy (PISE) demonstrated significant variations among groups (Fs =2.856; p = 0.05). Tukey-Kramer test showed significant variations for ischemic stroke (IS) subjects vs. post-ischemic stroke epilepsy (PISE) subjects. Stress and depression, lack of physical activity and personal or family history of stroke or TIA presented significant difference (p < 0.05). Conclusively, more work is needed to be carried out to understand the precise role of premenstrual estradiol in ischemic stroke and post-ischemic stroke epilepsy.
Publication Details
Page(s) 345-350
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 16, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Risk Factors, Ischemic Stroke, premenstrual, post-ischemic stroke epilepsy, estradiol 17-ß
0

Citations

0

Downloads

60

Views